Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database)

Gandhi, S. K., Reiffel, J. A., Boiron, R., & Wieloch, M. (2021). Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database). The American Journal of Cardiology, 159, 79–86. https://doi.org/10.1016/j.amjcard.2021.08.015
Authors:
Sampada K Gandhi
James A Reiffel
Rania Boiron
Mattias Wieloch
Affiliated Authors:
James A Reiffel
Columbia Affiliation:
Subjects:
Anti-Arrhythmia Agents (MeSH)
Atrial Fibrillation (MeSH)
Dronedarone (MeSH)
Factor Xa Inhibitors (MeSH)
Hemorrhage (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/j.amjcard.2021.08.015
PMID:
34656316
DOI:
10.1016/j.amjcard.2021.08.015
Journal:
American Journal of Cardiology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: